DYNAMICS OF MORPHOLOGICAL CHANGES IN BRACHIOCEPHALIC TRUNK ARTERIES INFLUENCED OF ATORVASTATIN THERAPY IN PATIENTS OF HIGH RISK


Cite item

Full Text

Abstract

Aim - to assess the morphological changes in the extracranial arteries of the brachiocephalic trunk in high-risk patients during atorvastatin therapy. Materials and methods. The study included 78 patients with a high risk of death from cardiovascular disease (mean age 54.8 ± 4.4 years), according to SCORE > 5% and <10%, with a moderately elevated level of OX (5.0-5.9 mmol/l) and LDL cholesterol (3.0-3.9 mmol/l) receiving atorvastatin at an initial dose of 40 mg/day. Results. In the presented group of patients, atherosclerotic lesion was more often observed in the common carotid artery (CCA), equally expressed on both sides. On the background of therapy with atorvastatin, the greatest changes in terms of regression and stabilization of atherosclerotic plaques are noted in the CCA projection on the left. In 36 cases, during treatment, there is a decrease and stabilization of atherosclerotic plaques, in 2 cases - the thickness of the intima-media complex. In 14 patients regression of two previously visualized plaques was noted in the background of treatment, in 4 patients - regression of three plaques, in 4 patients - stabilization of two plaques. Conclusions. Atorvastatin in the treatment of patients at high risk of death from cardiovascular disease contributes to the stabilization of carotid atherosclerosis and reduces the levels of atherogenic lipoproteins.

About the authors

OA A Rubanenko

Samara State Medical University

Email: lesya.rubanenko@gmail.com
PhD, associate professor of faculty therapy department of Samara State Medical University, cardiologist. Address: 25-213 Novo-Sadovaya st., Samara, Russia, 443110. Tel + 7 (937) 188 77 80

References

  1. Scheen AJ. From atherosclerosis to atherothrombosis: from a silent chronic pathology to an acute critical event. Rev Med Liege. 2018;73(5-6):224-228.
  2. Olie RH, van der Meijden PEJ, Ten Cate H. The coagulation system in atherothrombosis: Implications for new therapeutic strategies. Res Pract Thromb Haemost. 2018;2(2):188-198. doi: 10.1002/rth2.12080
  3. Mitchell C, Korcarz CE, Gepner AD et al. Ultrasound carotid plaque features, cardiovascular disease risk factors and events: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 Jun 12. pii: S0021-9150(18)30312-5. doi: 10.1016/j.atherosclerosis.2018.06.005 [Epub ahead of print]
  4. Sargento-Freitas J, Pagola J, Rubiera M et al. Preferential effect of premorbid statins on atherothrombotic strokes through collateral circulation enhancement. EurNeurol. 2012;68(3):171-6.
  5. Рубаненко О.А. Коррекция дислипидемий у больных ишемической болезнью сердца категорий высокого и очень высокого риска. Аспирантский вестник Поволжья. Самара, 2009;3-4:65-68.
  6. Luo P, Wang L, Zhu H et al. Impact of Atorvastatin Combined with Ezetimibe for the Treatment of Carotid Atherosclerosis in Patients with Coronary Heart Disease. Acta Cardiol Sin. 2016;32(5):578-585.
  7. Wang J, Ai XB, Wang F Zou YW et al. Efficacy of ezetimibe combined with atorvastatin in the treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease. Int Angiol. 2017;36(5):467-473. doi: 10.23736/S0392-9590.17.03818-4
  8. Лищук В.А. Интеллектуальное обеспечение диагностики и лечения нарушений кровообращения. Лекции по сердечнососудистой хирургии. Под ред. Л.А. Бокерия. В 2-х т. Т. 1. М.: Издательство НЦССХ им. А.Н. Бакулева РАМН, 2001.
  9. Nakagomi A, Shibui T, Kohashi K et al. Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia. JAtheroscler Thromb. 2015;22(11):1158-71. doi: 10.5551/jat.29520
  10. Li Y, Gao S, An Y, Liu E, Zhao S. High dose atorvastatin therapy yields a better carotid atherosclerosis improvement in Chinese patients. Int J Cardiol. 2015;185:131-2. doi: 10.1016/j.ijcard.2015.03.126

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Rubanenko O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).